论文信息 - Prognostic Value of ACVRL1 Expression in Metastatic Colorectal Cancer Patients Receiving First‐line Chemotherapy With Bevacizumab: Results From the Triplet Plus Bevacizumab (TRIBE) Study - 字舞流文

Prognostic Value of ACVRL1 Expression in Metastatic Colorectal Cancer Patients Receiving First‐line Chemotherapy With Bevacizumab: Results From the Triplet Plus Bevacizumab (TRIBE) Study

M. Li | H. Lenz | Dongyun Yang | Wu Zhang | F. Loupakis | A. Falcone | S. Matsusaka | Y. Miyamoto | M. D. Berger | C. Cremolini | L. Salvatore | C. Antoniotti | Y. Ning | M. Schirripa | D. Hanna | S. Astrow | M. Moran | G. Zeger